Dror Bashan, PRESIDENT AND CEO at Protalix BioTherapeutics, Inc. (PLX), bought 112,903 shares at $1.40 ($158K) on 2023-10-19, disclosed to the SEC on 2023-10-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.40 | 48,387 | $68K | 42.8% |
| 2 | $1.40 | 48,387 | $68K | 42.8% |
| 3 | $1.41 | 16,129 | $23K | 14.4% |
| Total | $1.40 avg | 112,903 | $158K | 100% |
| Filing → |